Pigment epithelium derived factor (PEDF) prevents methyl methacrylate monomer-induced cytotoxicity in H9c2 cells
Li Xin, Tian Han, Jiao Tang, Xiaoyu Wang, Hao Zhang, Hongyan Dong, Kaijin Guo, Zhongming Zhang
Pigment epithelium derived factor (PEDF) prevents methyl methacrylate monomer-induced cytotoxicity in H9c2 cells
Acrylic bone cements are currently the most frequently and extensively used materials in orthopedic implant treatment. However, adverse effects have been described of acrylic bone cement on the cardiovascular system. In the present study, we examined the cytotoxicity of bone cement ingredient methyl methacrylate (MMA) to cardiomyocytes and the potential detoxifying effect of pigment epithelium-derived factor (PEDF) in H9c2 cells. We found that high concentration of MMA (>120 mmol/L) led to necrotic cell death in H9c2 cells. However, MMA at low concentrations (30-90 mmol/L) caused apoptosis. Pretreatment of PEDF prevented MMA-induced cytotoxicity. In addition, PEDF enhanced total superoxide dismutase activities, and decreased MMA-induced production of malonaldehyde. Furthermore, MMA-induced downregulation of Akt activity was suppressed by PEDF. PEDF also increased the levels of peroxisome proliferator activated receptor gamma (PPARg) and lysophosphatidic acids (LPA) through PEDF receptor. These results indicated that PEDF inhibited MMA-induced cytotoxicity through attenuating oxidative stress, activating the phosphatidylinositol 3-kinase (PI3K)/Akt pathway and/or PEDF receptor-LPA-PPARg pathways in H9c2 cells. PEDF may be explored as a candidate therapeutic agent for alleviating bone cement implantation syndrome during orthopedic surgery.
pigment epithelium-derived factor / oxidative stress / bone cement / methyl methacrylate
[1] |
Donaldson AJ, Thomson HE, Harper NJ ,
Pubmed
|
[2] |
Modig J, Busch C, Olerud S ,
Pubmed
|
[3] |
Clark DI, Ahmed AB, Baxendale BR ,
Pubmed
|
[4] |
Urban MK, Sheppard R, Gordon MA ,
Pubmed
|
[5] |
Parvizi J, Holiday AD, Ereth MH ,
Pubmed
|
[6] |
Byrick RJ, Forbes D, Waddell JP . A monitored cardiovascular collapse during cemented total knee replacement[J]. Anesthesiology, 1986, 65(2): 213–216
Pubmed
|
[7] |
Duncan JA. Intra-operative collapse or death related to the use of acrylic cement in hip surgery[J]. Anaesthesia, 1989, 44(2): 149–153
Pubmed
|
[8] |
Pikis S, Goldstein J, Spektor S . Potential neurotoxic effects of polymethylmethacrylate during cranioplasty[J]. J Clin Neurosci, 2015, 22(1): 139–143
Pubmed
|
[9] |
Alvarez Berastegui GR , Raza SM , Anand VK ,
Pubmed
|
[10] |
Ciapetti G, Granchi D, Savarino L ,
Pubmed
|
[11] |
Gough JE, Downes S. Osteoblast cell death on methacrylate polymers involves apoptosis[J]. J Biomed Mater Res, 2001, 57(4): 497–505
Pubmed
|
[12] |
Yamada M, Ogawa T. Chemodynamics underlying N-acetyl cysteine-mediated bone cement monomer detoxification[J]. Acta Biomater, 2009, 5(8): 2963–2973
Pubmed
|
[13] |
Yasuda I, Iwatsuki K. Direct effects of acryl bone cement monomer on isolated heart muscle[J]. Tohoku J Exp Med, 1975, 117(1): 93–97
Pubmed
|
[14] |
King GL, Suzuma K. Pigment-epithelium-derived factor--a key coordinator of retinal neuronal and vascular functions[J]. N Engl J Med, 2000, 342(5): 349–351
Pubmed
|
[15] |
Haribalaganesh R, Sheikpranbabu S, Elayappan B ,
Pubmed
|
[16] |
Elahy M, Baindur-Hudson S, Cruzat VF ,
Pubmed
|
[17] |
Hyland J, Robins RH. Cardiac arrest and bone cement[J]. Br Med J, 1970, 4(5728): 176–177
Pubmed
|
[18] |
Zhang J, Liu W, Schnitzler V ,
Pubmed
|
[19] |
Tan H, Yang S, Dai P ,
Pubmed
|
[20] |
Singh V, Bhakta P, Zietak E ,
Pubmed
|
[21] |
Kim KJ, Chen DG, Chung N ,
Pubmed
|
[22] |
Aita H, Tsukimura N, Yamada M ,
Pubmed
|
[23] |
Notari L, Baladron V, Aroca-Aguilar JD ,
Pubmed
|
[24] |
Gendaszewska-Darmach E . Lysophosphatidic acids, cyclic phosphatidic acids and autotaxin as promising targets in therapies of cancer and other diseases[J]. Acta Biochim Pol, 2008, 55(2): 227–240
Pubmed
|
[25] |
Abdel-Raheem IT, Omran GA, Katary MA . Irbesartan, an angiotensin II receptor antagonist, with selective PPAR-gamma-modulating activity improves function and structure of chemotherapy-damaged ovaries in rats[J]. Fundam Clin Pharmacol, 2015, 29(3): 286–298
Pubmed
|
[26] |
Toba H, Miki S, Shimizu T ,
Pubmed
|
[27] |
Wang X, Zhang Y, Lu P ,
Pubmed
|
[28] |
Sussman MA, Völkers M, Fischer K ,
Pubmed
|
[29] |
Riaz A, Huang Y, Johansson S . G-protein-coupled lysophosphatidic acid receptors and their regulation of AKT signaling[J]. Int J Mol Sci, 2016, 17(2): 215
Pubmed
|
[30] |
Zhuang W, Zhang H, Pan J ,
Pubmed
|
/
〈 | 〉 |